Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA)

5 days ago 3

Soumya Eswaran

Thu, December 11, 2025 astatine 8:22 AM CST 3 min read

Arquitos Capital Management, an concern absorption firm, released its third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. During the 3rd quarter, the money delivered a nett instrumentality of 29.6% bringing year-to-date gains to an awesome 66.8%. Arquitos Capital Management is an unconventional hedge money that focuses connected a prime radical of companies. They are besides prepared to clasp these companies for galore years, sometimes adjacent decades, arsenic their businesses turn and the marketplace yet realizes their worth. In addition, you tin cheque the fund’s apical 5 holdings to find retired its champion picks for 2025.

In its third-quarter 2025 capitalist letter, Arquitos Capital Management highlighted stocks specified arsenic Liquidia Corporation (NASDAQ:LQDA). Liquidia Corporation (NASDAQ:LQDA) is simply a biopharmaceutical institution that develops, manufactures, and commercializes assorted products for unmet diligent needs successful the United States. The one-month instrumentality for Liquidia Corporation (NASDAQ:LQDA) was 21.31%, and its shares gained 196.82% implicit the past 52 weeks. On December 10, 2025, Liquidia Corporation (NASDAQ:LQDA) banal closed astatine $32.68 per share, with a marketplace capitalization of $2.843 billion.

Arquitos Capital Management stated the pursuing regarding Liquidia Corporation (NASDAQ:LQDA) successful its 3rd 4th 2025 capitalist letter:

"Liquidia Corporation's (NASDAQ:LQDA) stock terms roseate to $22.74 astatine the extremity of the 3rd quarter, up from $11.76 astatine the commencement of the year. Our vulnerability is chiefly done long-dated telephone options, reflecting my condemnation successful the company’s semipermanent potential.